448 related articles for article (PubMed ID: 12546003)
1. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
2. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
[TBL] [Abstract][Full Text] [Related]
4. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
5. The potential use of recombinant activated factor VII in trauma and surgery.
Sapsford W
Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Martinowitz U; Michaelson M;
J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
[TBL] [Abstract][Full Text] [Related]
8. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
9. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
Boffard KD; Choong PI; Kluger Y; Riou B; Rizoli SB; Rossaint R; Warren B;
Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
11. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA; Hoffman M; Roberts HR; Monroe DM
Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of recombinant-activated factor VII in neurocritical care.
Fewel ME; Park P
Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
[TBL] [Abstract][Full Text] [Related]
14. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
16. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
Mohr AM; Holcomb JB; Dutton RP; Duranteau J
Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
